METHOD OF TREATING BLURRED VISION AND OTHER CONDITIONS OF THE EYE WITH CYCLOSPORIN COMPOSITIONS
Disclosed herein is a method of treating blurred vision, of increasing keratocyte density, of increasing goblet cell density, and of treating psychological distress following surgery on the eye, the method comprising administering a cyclosporin composition to the affected eye of an individual.
1 . A method of increasing keratocyte density, the method comprising administering a cyclosporin composition to an eye of a subject having keratocyte loss or who would otherwise benefit from increased keratocyte density.
2 . The method of claim 1 , wherein the cyclosporin composition comprises cyclosporin A at a concentration from about 0.01% (w/v) to about 0.05% (w/v).
3 . A method of increasing goblet cell density, the method comprising administering a cyclosporin composition to an eye of a subject having goblet cell loss or who would otherwise benefit from increased goblet cell density.
4 . The method of claim 3 , wherein the cyclosporin composition comprises cyclosporin A at a concentration from about 0.01% (w/v) to about 0.05% (w/v).
5 . A method of treating psychological distress following surgery on the eye, the method comprising administering a cyclosporin composition to an eye of a subject in need of such treatment.
6 . The method of claim 5 , wherein the cyclosporin composition comprises cyclosporin A at a concentration from about 0.01% (w/v) to about 0.05% (w/v).
7 . A method of treating a patient having sensitivity to light, the method comprising topically administering a cyclosporin composition to an eye of a patient in need of such treatment.
8 . The method of claim 7 , wherein the cyclosporin composition comprises cyclosporin A at a concentration from about 0.01% (w/v) to about 0.05% (w/v).